dichlororibofuranosylbenzimidazole has been researched along with Cancer of Lung in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, LY | 1 |
| Jiang, YL | 1 |
| Tang, XW | 1 |
| Shan, B | 1 |
| Zhuo, Y | 1 |
| Chin, D | 1 |
| Morris, CA | 1 |
| Morris, GF | 1 |
| Lasky, JA | 1 |
| Lange-Carter, CA | 1 |
| Malkinson, AM | 1 |
3 other studies available for dichlororibofuranosylbenzimidazole and Cancer of Lung
| Article | Year |
|---|---|
[Effect of DRB/alpha-Amanitin on localization of Nrf2 in A549 cells].
Topics: 20-Hydroxysteroid Dehydrogenases; Alpha-Amanitin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; | 2010 |
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Culture Media, Conditioned; Cyclin T; Cyclin-Dependent Kinase 9; C | 2005 |
Differential regulation of the stability of cyclic AMP-dependent protein kinase messenger RNA in normal versus neoplastic mouse lung epithelial cells.
Topics: Animals; Blotting, Northern; Cycloheximide; Dichlororibofuranosylbenzimidazole; Epithelium; Gene Exp | 1991 |